STOCK TITAN

MATERION Corp (MTRN) SEC Filings, Aug-Sep 2026

MTRN NYSE

Welcome to our dedicated page for MATERION SEC filings (Ticker: MTRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MATERION's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MATERION's regulatory disclosures and financial reporting.

Rhea-AI Summary

MATERION Corp (MTRN) received a Form 144 notice from director Emily M. Liggett, indicating a proposed sale of restricted shares of the company’s common stock. The securities are held in the David & Emily Liggett Trust, with both David C. Liggett and Emily M. Liggett as trustees.

The notice covers up to 1,012 shares of common stock, to be sold through Charles Schwab on the NYSE, with an approximate sale date of September 1, 2026. These shares were originally acquired as Restricted Stock Units granted on May 18, 2021 as equity compensation from the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

MATERION Corp (MTRN) director Vinod M. Khilnani reported selling 2,000 shares of common stock on 2026-08-31 in an open market or private transaction at a weighted average price of $235.161 per share, with individual trade prices ranging from $234.980 to $235.830. After this sale, he holds 11,171 shares of MTRN common stock directly and 20,023.498 shares indirectly through a Directors Deferred Compensation Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MATERION Corp (MTRN) director Robert B. Toth reported internal family transfers of common stock on August 31, 2026. A bona fide gift of 28,832 shares held indirectly through his spouse was transferred to a family limited partnership, leaving him with 28,832 shares held indirectly through that partnership and none reported through his spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

MATERION Corp (MTRN) director Emily M. Liggett reported a bona fide gift of 1,609 shares of common stock on 2026-08-21, with no sale proceeds reported. After this gift, she holds 4,173 shares directly and 1,271.302 shares indirectly through a Directors Deferred Compensation Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MATERION Corp (MTRN) received a Rule 144 notice from director Vinod Khilnani regarding a proposed sale of common stock. The filing lists a planned sale of 2,000 common shares through Charles Schwab Corp, with an indicated aggregate value of $531,720.00 and 20,833,725 common shares shown as outstanding. The shares trace back to equity compensation awards granted in 2017 and 2018 for board service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

MATERION Corp director Robert B. Toth reported an internal transfer of common stock involving a bona fide gift. On 2026-08-10, he gifted 28,832 shares of Common Stock to his spouse, as disclosed in the footnote. His direct ownership decreased by 28,832 shares to 0 shares directly held, while the same number of shares is now reported as indirectly owned "By Spouse". No sale or purchase for value occurred, and the total reported family-related holdings remained 28,832 shares following the transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

MATERION Corp President and CEO Jugal K. Vijayvargiya exercised 24,594 Stock Appreciation Rights, converting them into an equal number of common shares at an exercise price of $68.82 per share. On the same date, 13,146 shares of common stock were delivered or withheld for payment of exercise price or tax liability at $296.00 per share. Vijayvargiya also reported open-market sales totaling 24,336 common shares at weighted-average prices within ranges generally between the high $287 and mid $296 per share. Post-transaction common share holdings are not specified in this report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MATERION Corp director Darlene J. S. Solomon reported selling 3,705 shares of common stock on 2026-08-07 in an open-market or private transaction. The weighted average sale price was $292.224 per share, with trades occurring between $292.190 and $292.690. Following this sale, she directly holds 26,718 shares of MATERION common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MATERION Corp Vice President, Finance & CFO Shelly Marie Chadwick exercised stock appreciation rights into 4,972 shares of common stock on August 7, 2026, including 2,800 shares at an exercise price of $135.58 and 2,172 shares at $87.36. On the same date, 3,267 shares of common stock were delivered or withheld for payment of exercise price or tax liability, and 1,705 shares were sold at $293.00 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many MATERION (MTRN) SEC filings are available on StockTitan?

StockTitan tracks 162 SEC filings for MATERION (MTRN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for MATERION (MTRN)?

The most recent SEC filing for MATERION (MTRN) was filed on September 1, 2026.